Suppr超能文献

胞质锤头状核酶的活性显著高于相应的核内对应物:具有延长3'末端的工程化tRNA能够在哺乳动物细胞中高效且特异地输出至胞质。

Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.

作者信息

Kuwabara T, Warashina M, Koseki S, Sano M, Ohkawa J, Nakayama K, Taira K

机构信息

Gene Discovery Research Center, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-4 Higashi, Tsukuba Science City 305-8562, Japan.

出版信息

Nucleic Acids Res. 2001 Jul 1;29(13):2780-8. doi: 10.1093/nar/29.13.2780.

Abstract

Hammerhead ribozymes were expressed under the control of similar tRNA promoters, localizing transcripts either in the cytoplasm or the nucleus. The tRNA(Val)-driven ribozyme (tRNA-Rz; tRNA with extra sequences at the 3' end) that has been used in our ribozyme studies was exported efficiently into the cytoplasm and ribozyme activity was detected only in the cytoplasmic fraction. Both ends of the transported tRNA-Rz were characterized comprehensively and the results confirmed that tRNA-Rz had unprocessed 5' and 3' ends. Furthermore, it was also demonstrated that the activity of the exported ribozyme was significantly higher than that of the ribozyme which remained in the nucleus. We suggest that it is possible to engineer tRNA-Rz, which can be exported to the cytoplasm based on an understanding of secondary structures, and then tRNA-driven ribozymes may be co-localized with their target mRNAs in the cytoplasm of mammalian cells.

摘要

锤头状核酶在类似的tRNA启动子控制下表达,使转录本定位于细胞质或细胞核中。我们在核酶研究中使用的由tRNA(Val)驱动的核酶(tRNA-Rz;3'端带有额外序列的tRNA)被高效输出到细胞质中,并且仅在细胞质部分检测到核酶活性。对转运的tRNA-Rz的两端进行了全面表征,结果证实tRNA-Rz具有未加工的5'和3'末端。此外,还证明输出的核酶的活性明显高于留在细胞核中的核酶。我们认为,基于对二级结构的理解,有可能设计出可输出到细胞质中的tRNA-Rz,然后tRNA驱动的核酶可能会在哺乳动物细胞的细胞质中与其靶mRNA共定位。

相似文献

2
Construction of a ribozyme-expression system that effectively transports ribozymes to the cytoplasm.
Nucleic Acids Symp Ser. 2000(44):203-4. doi: 10.1093/nass/44.1.203.
3
Transport of intracellularly active ribozymes to the cytoplasm.
Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S96-101. doi: 10.1007/s002800100314.
4
Ribozyme expression systems.
Methods Mol Biol. 2004;252:195-207. doi: 10.1385/1-59259-746-7:195.
7
Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.
J Virol. 1999 Mar;73(3):1868-77. doi: 10.1128/JVI.73.3.1868-1877.1999.
9
Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes.
Nat Biotechnol. 1998 Oct;16(10):961-5. doi: 10.1038/nbt1098-961.

引用本文的文献

1
Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.
J Virol. 2011 Feb;85(3):1370-83. doi: 10.1128/JVI.01250-10. Epub 2010 Nov 24.
2
Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.
Mol Ther. 2009 Sep;17(9):1563-73. doi: 10.1038/mt.2009.123. Epub 2009 Jun 16.
4
tRNA-linked molecular beacons for imaging mRNAs in the cytoplasm of living cells.
Nucleic Acids Res. 2005 Apr 4;33(6):1902-12. doi: 10.1093/nar/gki302. Print 2005.
5
Targeting mortalin using conventional and RNA-helicase-coupled hammerhead ribozymes.
EMBO Rep. 2003 Jun;4(6):595-601. doi: 10.1038/sj.embor.embor855.
8
Functional repair of a mutant chloride channel using a trans-splicing ribozyme.
J Clin Invest. 2002 Dec;110(12):1783-9. doi: 10.1172/JCI16481.
10
Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1.
Nucleic Acids Res. 2002 Sep 15;30(18):4001-8. doi: 10.1093/nar/gkf522.

本文引用的文献

2
RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA.
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5572-7. doi: 10.1073/pnas.091411398.
3
Recent advances in the elucidation of the mechanisms of action of ribozymes.
Nucleic Acids Res. 2001 May 1;29(9):1815-34. doi: 10.1093/nar/29.9.1815.
5
Allosterically controllable ribozymes with biosensor functions.
Curr Opin Chem Biol. 2000 Dec;4(6):669-77. doi: 10.1016/s1367-5931(00)00150-2.
6
Working at the cutting edge: the creation of allosteric ribozymes.
Structure. 2000 Nov 15;8(11):R207-12. doi: 10.1016/s0969-2126(00)00517-7.
7
Allosterically controllable maxizymes cleave mRNA with high efficiency and specificity.
Trends Biotechnol. 2000 Nov;18(11):462-8. doi: 10.1016/s0167-7799(00)01498-0.
8
Oncogene inactivation in a mouse model.
Nature. 2000 Aug 3;406(6795):473-4. doi: 10.1038/35020190.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验